Order Article Reprints

Solomon VR, Barreto K, Bernhard W, Alizadeh E, Causey P, Perron R, Gendron D, Alam MK, Carr A, Geyer CR, et al. Nimotuzumab Site-Specifically Labeled with ⁸⁹Zr and ²²⁵Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers. Cancers. 2020; 12(11):3449. https://doi.org/10.3390/cancers12113449

Solomon, Viswas Raja, Kris Barreto, Wendy Bernhard, Elahe Alizadeh, Patrick Causey, Randy Perron, Denise Gendron, Md. Kausar Alam, Adriana Carr, C. Ronald Geyer, and et al. 2020. "Nimotuzumab Site-Specifically Labeled with ⁸⁹Zr and ²²⁵Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers" Cancers 12, no. 11: 3449. https://doi.org/10.3390/cancers12113449

Solomon, V. R., Barreto, K., Bernhard, W., Alizadeh, E., Causey, P., Perron, R., Gendron, D., Alam, M. K., Carr, A., Geyer, C. R., & Fonge, H. (2020). Nimotuzumab Site-Specifically Labeled with ⁸⁹Zr and ²²⁵Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers. Cancers, 12(11), 3449. https://doi.org/10.3390/cancers12113449